Company intelligence / Profile preview

Rivanna Pharmaceuticals

Charlottesville, Virginia, United States

Ownership: Private
Development stage: Other

Overview

Rivanna Pharmaceuticals was a biopharmaceutical company based in Charlottesville, Virginia, founded in 2004. The company specialized in the discovery and development of novel small molecule therapeutics for central nervous system (CNS) disorders and various cancers, including prostate and colon cancer. It utilized a proprietary platform combining theoretical molecular design with practical hypothesis testing to identify compounds with high affinity for specific targets. The company was co-founded by Dr. Milton Brown and Mark Bussard but is currently inactive and considered "deadpooled."

Therapeutic areas: OncologyNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Rivanna Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rivanna Pharmaceuticals.

Explore the full profile